Mltx Stock Analysis Moonlake Immunotherapeutics At 17.36 Posts 5.08 Percent Gain 20260403 1 TNDM Q1 2026 Earnings Narrowing Loss Surpasses Expectations Stock Dips on Cautious Outlook PBF Energy Q1 2026 Earnings Refining Headwinds Drive WiderThanExpected Loss HOG Q1 2026 Earnings EPS Beats Estimates by 117 as Shares Rise Gartner IT Q1 2026 Earnings EPS Smashes Estimates Stock Rises on Strong Execution KULR Q3 2025 Earnings Massive EPS Miss Highlights Ongoing Challenges ATRO Q1 2026 Earnings EPS Beats Estimates Stock Rises Slightly